Company Profile: BioMarck Pharmaceuticals Ltd.

CED Life Science Conference 2017 - Innovation Room

www.biomarck.com                                                                      
Sub-sector: Biotech and Pharmaceutical
Year Founded: 2004

COMPANY PROFILE
Biomarck is a biopharmaceutical company with a patented technology platform. We utilize anti-MARCKS peptides in order to develop and license products targeted at difficult to treat diseases with unmet needs. We are located in Research Triangle Park, N.C. Our company has a worldwide patented drug platform of over 100 peptides that inhibit the phosphorylation of the MARCKS protein, a well published primary mediator of an inflammatory cytokine release involved in respiratory disease and cancer progression.

FOUNDERS/MANAGEMENT TEAM
Dr. Brian Dickson, Chief Executive Officer
Dr. Indu Parikh, Chief Scientific Officer

KEY MILESTONES TO DATE

  • IND's submitted. Phase 1 completed

POWERED BY
NC State Office of Technology Transfer (OTT)

CONTACT
Brian Dickson
bdickson@biomarck.com
Durham, NC

Learn more about the CED Life Science Conference.